Anna Tate Riegel
About Anna Tate Riegel
Anna Tate Riegel is the Vice President for Biomedical Education and Research of Biomedical Graduate Education and the Celia Rudman Fisher Endowed Professor of Oncology and Pharmacology at Georgetown University. She has over 25 years of experience in cancer research, focusing on genetic and epigenetic mechanisms, and has mentored numerous pre-doctoral, postdoctoral fellows, and junior faculty.
Title
Anna Tate Riegel is the Vice President for Biomedical Education and Research of Biomedical Graduate Education. She currently holds the prestigious position of Celia Rudman Fisher Endowed Professor of Oncology and Pharmacology.
Education and Expertise
Anna Tate Riegel holds a PhD, underlining her extensive academic background and expertise in biomedical fields. Her knowledge and skills are primarily focused on genetic and epigenetic mechanisms in cancer research, areas in which she has made significant contributions over more than 25 years.
Professional Background
Anna Tate Riegel has a history of involvement with Georgetown University, where she worked briefly as a Professor in 1970. She is also associated with the Georgetown Lombardi Comprehensive Cancer Center, contributing significantly to its research mission.
Cancer Research
Anna Tate Riegel has dedicated more than 25 years to cancer research. Her work primarily focuses on genetic and epigenetic mechanisms, exploring the underlying factors of cancer development and progression. She has made substantial contributions to the field through her research and academic initiatives.
Mentorship
Anna Tate Riegel has mentored 23 pre-doctoral and 13 postdoctoral fellows. She has also guided several junior faculty members, helping them to advance to significant positions in academia, biotechnology industries, and science-related policy positions. Her mentorship has been pivotal in shaping future leaders in these fields.